GENEVA, Sept. 18 -- AETON THERAPEUTICS, INC. filed a patent application (US2026/017646) for “METHODS OF TREATMENT AND DIAGNOSIS USING ANTI-ACETYLATED TAU ANTIBODIES”. With publication no. WO/2026/187868, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 33/53

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....